GeneDx Holdings Corp. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
GeneDx Holdings Corp. (WGS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $45.37 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-08-03
- GeneDx Holdings Corp. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-03-31 was $45.37, a 2.99% decline year-over-year.
- GeneDx Holdings Corp. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-03-31 was $46.77.
- GeneDx Holdings Corp. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2021-03-31 was $14.89.
- GeneDx Holdings Corp. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $23.30, a 32.31% decline from fiscal 2024.
- GeneDx Holdings Corp. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $34.42, a 37.30% increase from fiscal 2023.
- GeneDx Holdings Corp. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $25.07, a 1517.42% increase from fiscal 2022.
- GeneDx Holdings Corp. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $1.55, a 68.81% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $45.37 10-Q · filed 2026-08-03 | |||
| 2026-03-31 | $45.37 10-Q · filed 2026-05-04 | |||
| 2025-12-31 | $23.30 10-K · filed 2026-02-23 | |||
| 2025-09-30 | $46.60 10-Q · filed 2025-10-28 | |||
| 2025-06-30 | $46.76 10-Q · filed 2025-07-29 | |||
| 2025-03-31 | $46.77 10-Q · filed 2025-04-30 | |||
| 2024-12-31 | $34.42 10-K · filed 2026-02-23 | |||
| 2023-12-31 | $25.07 10-K · filed 2026-02-23 | |||
| 2022-12-31 | $1.55 10-K · filed 2023-03-16 | |||
| 2021-12-31 | $4.97 10-K · filed 2022-03-14 | |||
| 2021-06-30 | $14.01 10-Q · filed 2021-07-21 | |||
| 2021-03-31 | $14.89 10-Q · filed 2021-05-24 | |||
| 2020-12-31 | $11.04 10-Q · filed 2021-07-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |